title: Toxic erythema of chemotherapy with periorbital and perioral involvement.
abstract: Toxic erythema of chemotherapy (TEC) refers to a group of chemotherapy-induced cutaneous toxicities. We present a case of TEC in an 11-year-old girl who received gemcitabine and docetaxel for osteosarcoma of the femur.
authors.affiliation: Department of Internal Medicine, Singapore General Hospital, Singhealth Services, Singapore.
authors.forename: Evelyn Yuxin
authors.initials: EY
authors.lastname: Tay
authors.forename: Yen Loo
authors.initials: YL
authors.lastname: Lim
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001365:Axilla; D001859:Bone Neoplasms / Q000188:drug therapy; D002648:Child; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077143:Docetaxel; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D005269:Femur / Q000473:pathology; D006801:Humans; D017495:Hyperpigmentation; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D009055:Mouth / Q000187:drug effects*; D009915:Orbit / Q000187:drug effects*; D012516:Osteosarcoma / Q000188:drug therapy; D043823:Taxoids / Q000009:adverse effects*; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D000093542:Gemcitabine